NG83 provides evidence-based guidance on diagnosing and treating oesophageal and gastric cancers, standardising UK clinical practice and improving patient outcomes.
NICE NG85 provides evidence-based guidance on diagnosing and managing pancreatic cancer in adults, ensuring UK clinicians deliver consistent, high-quality patient care.
NICE NG14 provides evidence-based guidelines for diagnosing and treating melanoma in the UK, ensuring consistent, high-quality patient care across the NHS.
NICE NG241 provides evidence-based guidance on recognizing ovarian cancer symptoms and initial management, improving early diagnosis and patient outcomes across UK healthcare.
NICE NG131 provides evidence-based prostate cancer diagnosis and management guidance, ensuring UK clinicians deliver consistent, high-quality, patient-centered care nationwide.
NICE NG151 provides evidence-based guidance on diagnosing and treating colorectal cancer, essential for standardizing care across UK healthcare services.
TA1026 recommends tirzepatide as a weight-loss treatment for overweight/obese adults, guiding NHS prescribing decisions and improving patient access to effective therapy.
NICE NG3 provides evidence-based guidance on gestational diabetes screening, diagnosis and management to improve maternal and fetal outcomes across UK healthcare.